Nektar Therapeutics (NKTR) Insider Trading & Ownership $1.33 +0.10 (+8.13%) (As of 05:39 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Nektar Therapeutics (NASDAQ:NKTR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.71%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$227,143.14 Get NKTR Insider Trade Alerts Want to know when executives and insiders are buying or selling Nektar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NKTR Insider Buying and Selling by Quarter Ad Porter & CompanyThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you. Nektar Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/19/2024Howard W RobinCEOSell14,881$1.28$19,047.68 8/19/2024Jonathan ZalevskyInsiderSell6,866$1.28$8,788.48 6/14/2024Robert ChessDirectorSell19,500$1.20$23,400.00 5/17/2024Howard W RobinCEOSell16,650$1.75$29,137.50 5/17/2024Jonathan ZalevskyInsiderSell7,355$1.75$12,871.25 5/10/2024Deep Track Capital, LpMajor ShareholderSell56,000$1.78$99,680.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/20/2024Howard W RobinCEOSell20,033$0.68$13,622.44 2/20/2024Jonathan ZalevskyInsiderSell9,014$0.68$6,129.52 11/17/2023Howard W RobinCEOSell19,877$0.49$9,739.73 11/17/2023Jonathan ZalevskyInsiderSell9,646$0.49$4,726.54 (Data available from 1/1/2013 forward) NKTR Insider Trading Activity - Frequently Asked Questions Who is on Nektar Therapeutics's Insider Roster? The list of insiders at Nektar Therapeutics includes Deep Track Capital, Lp, Gil M Labrucherie, Howard W Robin, Jillian B Thomsen, John Northcott, Jonathan Zalevsky, Karin Eastham, Mark Andrew Wilson, Myriam Curet, Robert Chess, and Roy A Whitfield. Learn more on insiders at NKTR. What percentage of Nektar Therapeutics stock is owned by insiders? 3.71% of Nektar Therapeutics stock is owned by insiders. Learn more on NKTR's insider holdings. Which Nektar Therapeutics insiders have been selling company stock? The following insiders have sold NKTR shares in the last 24 months: Deep Track Capital, Lp ($99,680.00), Howard W Robin ($296,420.69), Jillian B Thomsen ($70,410.15), Jonathan Zalevsky ($126,637.85), Myriam Curet ($3,007.71), Robert Chess ($23,400.00), and Roy A Whitfield ($17,100.00). How much insider selling is happening at Nektar Therapeutics? Insiders have sold a total of 376,989 Nektar Therapeutics shares in the last 24 months for a total of $636,656.40 sold. Nektar Therapeutics Key ExecutivesMr. Howard W. Robin (Age 71)CEO, President & Director Compensation: $1.83M2 recent tradesMr. Mark A. Wilson (Age 52)Senior VP, Chief Legal Officer & Secretary Compensation: $749.99kDr. Jonathan Zalevsky Ph.D. (Age 49)Chief Research & Development Officer Compensation: $1.25MMs. Sandra A. Gardiner (Age 58)Interim Chief Financial Officer Vivian WuDirector of Investor Relations & Corporate AffairsMr. Robert BacciSenior Vice President of Human Resources & Facilities OperationsMs. Jennifer RuddockChief Business OfficerDr. Mary Tagliaferri L.Ac. (Age 58)M.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ADCT Insider Buying AVIR Insider Buying MCRB Insider Buying PCRX Insider Buying OMER Insider Buying ASMB Insider Buying CPIX Insider Buying AGIO Insider Buying ALKS Insider Buying NVO Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (NASDAQ:NKTR) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nektar Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Nektar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NKTR Stock Alerts